Chiron Will Produce Investigational Avian Flu Vaccine For NIH Clinical Trials

The National Institute of Allergy & Infectious Diseases will conduct safety and immunogenicity studies of the H9N2-based vaccine under an IND. Chiron will produce up to 40,000 doses for testing.